(Waterloo, June 9 2026) – With the project “Triaging artificial intelligence (AI) Tool For Pulmonary Health Using Spectral X-ray Imaging Technology”, KA Imaging has been selected for INOVAIT’s Pilot Fund.
The project will develop an AI-based triage tool using data from Reveal 35C with SpectralDR technology to rapidly detect cardiothoracic abnormalities relevant to image-guided interventions.
“The project will leverage data generated by the Reveal 35C detector with SpectralDR technology, which has demonstrated improved visualization of foreign bodies, pulmonary nodules, consolidation, pleural fluid, pneumothorax, and other findings in clinical studies,” said Karim S. Karim, Founder and CTO of KA Imaging. “The AI is intended to assist non-radiologist clinicians in identifying potential findings before and after image-guided interventions, with the goal of improving efficiency within clinical imaging workflows,” he continued.
The proposed Triaging AI Tool also involves collaboration with Dr. Elliot Creager at the University of Waterloo, an expert in AI and machine learning (ML). His research focuses on developing advanced ML methods for complex data analysis, providing strong academic expertise in AI model development and evaluation.
The resulting software is expected to be demonstrated in 2027. After successful development, validation, and regulatory clearances, it is expected to automatically analyze bedside spectral X-rays, flag suspected findings, and prioritize cases for clinician review within existing imaging workflows.
Following the Pilot phase, the technology will be evolved into a deployable AI software product integrated with KA Imaging’s mobile spectral X-ray systems.
“Innovation doesn’t happen in isolation. Programs run by networks like INOVAIT create the connections between researchers, clinicians, and industry that help turn promising technologies into practical healthcare solutions,” said Amol Karnick, president and CEO of KA Imaging. “This second INOVAIT-supported project reflects the strength of Canada’s medical imaging innovation ecosystem,” said Karnick.
The Pilot Fund is designed to encourage the commercial translation of research and development within the image-guided therapy and artificial intelligence sectors. The successful project recipients will use advances in data sciences and artificial intelligence to enhance image guidance and corresponding therapies.
“KA Imaging is leading x-ray innovation in Canada,” says Raphael Ronen, Co-executive director of INOVAIT. “We’re proud to support their Pilot Fund project that has the potential to transform patient outcomes and reduce healthcare costs in Canada.”
Funding for this project was provided in part by INOVAIT through the Government of Canada’s Strategic Response Fund.
Ce projet a été financé en partie par INOVAIT dans le cadre du Fonds de réponse stratégique du gouvernement du Canada.
About KA Imaging:
A spin-off from the University of Waterloo, KA Imaging specializes in innovative X-ray imaging technologies and systems. Powered by patented SpectralDR technology, KA Imaging’s healthcare product line includes retrofit solutions and mobile systems featuring the Reveal 35C detector, which enables single-exposure dual-energy imaging. Clinical studies using the Reveal 35C detector have demonstrated enhanced visualization of line and tube ends, retained surgical objects, pneumothorax, bedside pneumonia, coronary calcium, and other findings. KA Imaging aims to improve image quality and achieve bone/tissue differentiation in mobile systems while maintaining the ease and simplicity of X-ray.
About INOVAIT:
INOVAIT is a pan-Canadian network funded by the Government of Canada and hosted at the Sunnybrook Research Institute with the objective of building a truly integrated image-guided therapy and artificial intelligence (AI) ecosystem, fueling continuous innovation that revolutionizes healthcare globally. Through connecting, educating, and investing in the industry’s brightest minds and most promising ventures, INOVAIT supports collaborative development and integration of AI into medical technologies.
Financé par le gouvernement du Canada et situé à l’Institut de recherche Sunnybrook, INOVAIT est un réseau pancanadien dont l’objectif est de créer un écosystème de thérapie guidée par imagerie et l’intelligence artificielle (IA) véritablement intégré qui favorise l’innovation continue et révolutionne les soins de santé à l’échelle mondiale. Grâce à l’établissement de liens, à la formation et à la réalisation d’investissements au profit des plus brillants cerveaux et des initiatives les plus prometteuses du secteur, INOVAIT soutient le développement collaboratif ainsi que l’intégration de l’IA dans les technologies médicales.